Senate Democrats question IRS chief over staffing testimony
Lawmakers led by Elizabeth Warren asked Frank Bisignano to explain testimony that the IRS was not understaffed as reports point to...
By Marcus V. Thorne 1 month agoSection
Lawmakers led by Elizabeth Warren asked Frank Bisignano to explain testimony that the IRS was not understaffed as reports point to...
By Marcus V. Thorne 1 month agoSaudi Arabia confirmed one tanker was hit in the Red Sea, while US forces reported a 12th straight round of strikes on Iran.
By Marcus V. Thorne 1 month agoFord will hold 66% of a new venture with Geely to produce electric vehicles at its Valencia plant, subject to regulatory clearance...
By Amanda Ross 1 month agoA Hyperliquid derivative has valued ChangXin Memory Technologies far above its IPO price, highlighting investor access limits and...
By Sarah Jenkins 1 month agoComcast beat profit estimates as Peacock turned profitable, while broadband losses continued and connectivity revenue declined.
By Marcus V. Thorne 1 month agoMichael Kratsios alleged the Chinese AI firm accessed GB300 processors in Thailand as Washington weighs tighter controls on remote...
By Amanda Ross 1 month agoSpot silver and gold rose this week after recent selling, though major banks say rates, the dollar and positioning may limit furth...
By Amanda Ross 1 month agoBoth companies beat revenue expectations but reported negative free cash flow, putting Wall Street’s scrutiny of AI-related capita...
By Sarah Jenkins 1 month agoBill McDermott told CNBC that ServiceNow’s AI Control Tower can stop rogue AI agents as the company seeks to benefit from wider en...
By Sarah Jenkins 1 month agoCEO Flemming Ørnskov told CNBC that rising use of GLP-1 drugs is starting to support growth in Galderma’s aesthetics portfolio.
By Sarah Jenkins 1 month agoAmerican lowered its full-year adjusted EPS range after fuel volatility, while second-quarter revenue and adjusted profit topped L...
By Amanda Ross 1 month agoLilly said two late-stage studies showed weight loss of more than 20% in some patients, but regulatory filing will wait for manufa...
By Marcus V. Thorne 1 month ago